Everest Medicines Company

Everest Medicines is dedicated to its mission of developing and commercializing novel transformative pharmaceutical therapies for patients in the Emerging Market including Asia Pacific territories. We strive to be the partner of choice for innovative companies around the world with products that address critical unmet medical needs for patients in the Emerging Market and have a high probability of market approval. The Everest Medicines team has deep expertise and extensive track record of high quality clinical development, regulatory affairs, CMC, business development and operations both in Asia Pacific territories and with leading global pharmaceutical companies.
Technology: Biotechnology, Health Care, Pharmaceutical
Industry: Clinical Development
Headquarters: New York, New York, United States
Founded Date: 2017-01-01
Employees Number: 51-100
Funding Status: IPO
Investors Number: 10
Total Funding: 310000000
Estimated Revenue: $1M to $10M
Last Funding Date: 2020-06-03
Last Funding Type: Series C

Visit Website
Register and Claim Ownership